BidaskClub upgraded shares of Imperva (NASDAQ:IMPV) from a sell rating to a hold rating in a research report sent to investors on Friday, January 5th.
IMPV has been the topic of a number of other reports. Piper Jaffray Companies reiterated a neutral rating and issued a $58.00 price target on shares of Imperva in a report on Friday, October 13th. JPMorgan Chase & Co. downgraded shares of Imperva from a neutral rating to an underweight rating and set a $45.00 target price on the stock. in a report on Tuesday, December 12th. KeyCorp restated a hold rating on shares of Imperva in a report on Tuesday, October 24th. Evercore ISI restated a buy rating and issued a $56.00 target price on shares of Imperva in a report on Wednesday, November 8th. Finally, William Blair cut shares of Imperva from an outperform rating to a market perform rating in a research note on Tuesday, October 10th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of $51.86.
Shares of Imperva (IMPV) opened at $43.15 on Friday. The firm has a market cap of $1,470.00, a P/E ratio of 159.81 and a beta of 1.78. Imperva has a 1 year low of $37.17 and a 1 year high of $52.40.
Imperva (NASDAQ:IMPV) last issued its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.11. The company had revenue of $83.89 million for the quarter, compared to analysts’ expectations of $83.79 million. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The firm’s quarterly revenue was up 22.6% on a year-over-year basis. During the same quarter last year, the company posted $0.08 earnings per share. equities analysts anticipate that Imperva will post -0.52 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. ETF Managers Group LLC acquired a new position in Imperva during the 2nd quarter valued at approximately $41,888,000. Alyeska Investment Group L.P. increased its stake in Imperva by 89.3% during the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock valued at $39,390,000 after purchasing an additional 428,163 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec increased its stake in Imperva by 171.4% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 475,000 shares of the software maker’s stock valued at $20,702,000 after purchasing an additional 300,000 shares in the last quarter. BlackRock Inc. increased its stake in Imperva by 11.3% during the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after purchasing an additional 215,170 shares in the last quarter. Finally, Quantitative Investment Management LLC acquired a new position in Imperva during the 2nd quarter valued at approximately $8,546,000. Hedge funds and other institutional investors own 96.93% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/12/imperva-impv-stock-rating-upgraded-by-bidaskclub.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.